Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Cryptos Subdued But Bitcoin Firm Above $30k
  2. Facebook’s Former Head of Crypto Manages To Bash Ethereum Without Meaning To Do So
  3. Bears Drag Bitcoin to Lowest Price Level In Two Years — Where’s BTC Headed Next?
  4. Bitcoin ($BTC) Will Keep Going Up by 100% a Year, Says Analyst Preston Pysh
  5. Between Buoyant Earnings And Worrying Geopolitics – World Markets At This Hour